Home Editorial Snakebite, Antivenom, and the Failure of a System

Snakebite, Antivenom, and the Failure of a System

0
116

The recent tragic death of 26-year-old Abuja-based singer, Ifunanya Nwangene (known to many as Nanyah) should disturb our national conscience as it exposes systemic dysfunction that extends far beyond snakebite management. On 31 January 2026, Ms Nwangene was bitten by a snake while asleep in her home in the Federal Capital Territory. Despite being rushed to more than one facility for urgent care, she died later that day from complications related to the bite, after frantic efforts to secure the second dose of necessary anti-venom proved futile. Reports from her friends and music colleagues describe a desperate last-minute search to procure medicines that should have been available in the hospital stock.

Beyond the widespread mourning and outcry over the loss of the young, talented life, it is more imperative to confront the deeper issues that such a death reveals. A snakebite is a medical emergency long understood, clinically manageable, and rarely fatal where functional systems exist. Yet in Nigeria’s Federal Capital Territory, a patient reportedly criss-crossed the uncertainty of treatment logistics, medicine access, and referral limitations under circumstances where minutes often determine survival. That reality is not merely unfortunate; it is structurally indefensible.

Globally, snakebites kill an estimated 100,000 people annually and leave hundreds of thousands with permanent disabilities. Nigeria bears a disproportionate share of this burden, particularly in agrarian communities. But what makes the Abuja incident especially troubling is not the epidemiology of snakebite but the geography. If essential antidotes cannot be reliably accessed within the nation’s capital, what confidence can rural Nigerians reasonably place in the emergency care architecture?

But even more disconcerting is that tragedies of this nature are not aberrations but symptoms of a system whose weaknesses are extensively documented yet rarely addressed. According to the latest World Health Organisation-derived estimates, maternal mortality stands at over 900 deaths per 100,000 live births, more than double the average for lower-middle-income African countries, while under-five and infant mortality remain alarmingly high. Malaria, a generally preventable and treatable disease, accounts for a disproportionate share of morbidity and mortality, with Nigeria responsible for a substantial proportion of global cases and deaths.

A major health ministerial briefing noted that Nigeria’s doctor-to-population ratio stands around 1:5,000, sharply below the WHO benchmark of 1:600, and that health spending hovers near 5 per cent of GDP, far below the 15 per cent Abuja Declaration commitment first agreed by African states in 2001.

What all these reveals is a health system ill-equipped to manage common, predictable health threats, much less time-sensitive emergencies like snakebite.  Curiously, this lack of readiness is not for want of policy rhetoric. Successive governments have spoken of health sector reforms, universal health coverage and local production of medicines, yet budgetary allocations remain abysmal (far below the 15 per cent stipulated by the Abuja Declaration), poorly targeted, and often consumed by recurrent expenditures rather than strategic capital investments in infrastructure and supply chains. The neglect of primary healthcare, the first point of contact for emergencies in every community, compounds the problem, leaving patients to seek care in shambolic facilities or face crippling costs in private hospitals.

It is essential, therefore, to channel the grief over Ms Nwangene’s death into concrete corrective action. Health budgets must be substantially increased with clear earmarks for emergency care readiness, essential medicines and health workforce development. Nigeria must move beyond token budget increases to funding that reflects the scale of its disease burden and population needs. Accountability frameworks must be strengthened so that allocations result in measurable improvements in service delivery rather than disappearing into administrative inefficiencies.

Crucially, emergency medicine protocols, including guaranteed stock levels of essential antidotes such as snake antivenom, insulin, and cardiac drugs, must be made part of licencing standards for all hospitals, backed by regular audits and enforcement. Strengthened surveillance and transparent reporting mechanisms will help map gaps and direct resources where they are most needed.

The nation’s pharmaceutical ecosystem must also be revolutionised. Heavy dependence on imported medicines and raw materials leaves the country vulnerable to global supply shocks and currency volatility. Strategic investment in local manufacturing, regulation, quality assurance and distribution is not optional; it is foundational to achieving medicine security and insulating the health system from avoidable shortages.

Ms Nwangene’s passing must be a turning point in Nigeria’s pursuit of a capable, responsive and equitable health system. The nation’s future is predominantly dependent on the restoration of a health system that works; a system where essential medicines are available, where healthcare workers are supported and where no one dies for want of basic care.

LEAVE A REPLY

Please enter your comment!
Please enter your name here